Revealing the secrets of cell competition
Which features distinguish “winner” from “loser” cells
Cellular competition is a crucial quality control process that ensures that the development of an organism relies on healthy cells. Researchers revealed the secrets underlying cell competition and what features can pre-determine whether a cell will survive or not. Defects in energy production are critical in making cells vulnerable to elimination. The study was led by researchers from Helmholtz Zentrum München and Imperial College London.

Mouse embryonic stem cells
Ana Lima / Imperial College London
As multicellular life relies on cell-cell interactions, it is not surprising that this is not always peaceful: cells with higher fitness eliminate cells with lower fitness through cell competition. Cell competition has emerged as a quality control mechanism and occurs when cells differ, genetically or otherwise, from each other. In mammals, the process of cell competition has been observed e.g., in cancer, during organ homeostasis, and during development as a process to select the fittest cells in the embryo and the adult. However, the features that distinguish “winner” from “loser” cells and whether there are key determinants for cell competition in various biological contexts remain elusive.
The recipe for elimination of “loser” cells
The research team found out that the cells losing the competition are characterized by defective mitochondria and, in mouse embryos, they are marked by sequence changes in their mitochondrial genome. Their work was published in the journal Nature Metabolism. “Our work suggests that differences in mitochondrial activity are key determinants of competitive cell fitness in a wide range of systems. In particular, we discovered that genetic defects in the mitochondria characterize ‘loser’ cells in mouse embryos,” says Antonio Scialdone, co-corresponding author of the article.
In more detail: The mouse embryo uses cellular competition to get rid of unfit epiblast cells before the basic body plan is laid down during gastrulation. Using single-cell RNAseq (a specific sequencing technique), the researchers compared cells in embryos treated with a cell death inhibitor versus those in untreated mouse embryos. By applying machine learning algorithms, they could identify the gene expression signature of “loser” cells and discovered that these cells have defective mitochondria and are marked by sequence changes in their mitochondrial genome. “It was nice to see how with our computational pipeline we were able to extract such important information from the single-cell RNAseq datasets,” says Gabriele Lubatti co-first author of the article.
The information on how “loser” cells look like in the mouse embryo allowed them to determine a ”loser” cell identity. By analyzing the mitochondrial activity in other cell competition models, they could identify that mitochondrial dysfunction is a common characteristic in different “loser” cells and that small changes in the mitochondrial DNA are enough to drive cell competition.
Future work
This study suggests that mitochondrial activity may be a key determinant of cellular fitness in a variety of contexts where competition between cells occurs. Environmental changes can strongly influence metabolism and mitochondria play a central role in this process. Therefore, it is possible that cellular competition and associated defects in the mitochondrial genome in response to certain environmental factors leads to the emergence of a particular genotype (“winner” cells). This implies that cellular competition could be a direct link between environment and genotype, which will be interesting to explore further.
Original publication
Original publication
Lima et al.; "Cell competition acts as a purifying selection to eliminate cells with mitochondrial defects during early mouse development"; Nature Metabolism; 2021
Topics
Organizations
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Merck Intends to Submit Cladribine Tablets to Treat Multiple Sclerosis for Registration in Europe - Decision based on data available from the Cladribine Tablets clinical program and performed analyses
Decriminalization_of_non-medical_marijuana_in_the_United_States
Category:Pseudomonadales

Proscan elektronische Systeme GmbH - Graben, Germany

Pharmacoscopy: Next-Generation Microscopy - New possibilities for drug discovery
New triggerable, tough hydrogels could make drug-releasing systems safer
